EP Patent

EP0372541A1 — Method for imparting immunosuppression

Assigned to GD Searle LLC · Expires 1990-06-13 · 36y expired

What this patent protects

A method for imparting immunosuppression in a patient in need thereof is performed by administering an immunosuppressive agent containing cyclosporine and administering an E-type prostaglandin in an immunosuppressive-agent-enhancing effective dose.

USPTO Abstract

A method for imparting immunosuppression in a patient in need thereof is performed by administering an immunosuppressive agent containing cyclosporine and administering an E-type prostaglandin in an immunosuppressive-agent-enhancing effective dose.

Drugs covered by this patent

Patent Metadata

Patent number: EP0372541A1
Jurisdiction: EP
Classification: —
Expires: 1990-06-13
Drug substance claim: No
Drug product claim: No
Assignee: GD Searle LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.